Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Fampridine and multiple sclerosis.]
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
Specific Contactin N-glycans are implicated in Neurofascin binding and autoimmune targeting in peripheral neuropathies.
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.
Analysis of symptoms, functional impairments, and participation in occupational therapy for individuals with multiple sclerosis.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue.
Alpha lipoic acid enhances endogenous peroxisome proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis.
Drawing on related knowledge to advance multiple sclerosis falls-prevention research.
Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum.
Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
(P150) assessment of acute and late toxicities of intracranial stereotactic radiosurgery in multiple sclerosis patients.
Longitudinally extensive transverse myelitis as presenting manifestation of small cell carcinoma lung.
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.

Pages